In the realm of reproductive health, the in vitro fertilisation (IVF) market sale is poised for a monumental ascent, projected to surge at a robust compound annual growth rate (CAGR) of 9.0% from 2022 to 2032, culminating in a substantial valuation of around US$ 1.6 billion.
At the core of this remarkable growth trajectory are two pivotal factors reshaping the landscape of fertility treatment worldwide. Firstly, a palpable decline in total fertility rates has underscored the urgent need for advanced reproductive solutions. As individuals and couples grapple with infertility challenges, the demand for assisted reproductive technologies such as IVF has surged, driven by a quest for viable pathways to parenthood.
Secondly, the phenomenon of “repro-tourism” has emerged as a significant catalyst fueling the expansion of the IVF market. Increasingly, individuals are seeking fertility treatments beyond their geographic borders, drawn by the promise of superior medical expertise, state-of-the-art facilities, and favorable regulatory environments. This trend underscores the global nature of infertility as a health concern and highlights the growing willingness of patients to explore cross-border healthcare options.
Indeed, infertility transcends geographical boundaries, impacting individuals and families across diverse cultures and regions. As a serious health issue with profound socio-economic implications, infertility demands innovative solutions and unwavering commitment from healthcare providers worldwide.
According to the American Pregnancy Association, male infertility accounts for 30% of infertility cases and leads to about one-fifth of infertility cases. The market will rise as people become more dependent on fertility treatments. The growing use of in vitro fertilization (IVF) techniques is being influenced by the availability of resources.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14305
The emergence of the COVID-19 pandemic prompted the cessation of fertility treatments, which had a psychological impact on the women who had their treatments discontinued. Treatment clinics are now allowed to resume treatments under the condition that they observe stringent requirements.
Culture medium, capital equipment, and IVF disposable devices make up the in vitro fertilization instrument. In 2020, culture media dominated the in vitro fertilization/IVF market and accounted for a large portion of the income. The availability of money and an increase in research initiatives to improve the culture media were credited with in vitro fertilization/IVF market expansion.
The disposable devices market, on the other hand, is predicted to increase at the quickest rate over the projection years, as the in vitro fertilization/IVF market participants provide disposable devices such as needles, slides, and chambers to fulfil sterility and regulatory criteria.
The sector of fertility clinics led the global the in vitro fertilization/IVF market, accounting for the majority of revenue. Throughout the projected period, the category is expected to maintain its leading the in vitro fertilization/IVF market position while increasing at the highest rate.
The rise of fertility clinics is expected to be fuelled by factors such as cost-effectiveness, availability of experts, and little or no risk of Hospital-Acquired Infections (HAIs). IVF procedures are also carried out in hospitals.
In 2020, the frozen non-donor segment dominated the global in vitro fertilization/IVF market. However, in 2020, the fresh non-donor sector had the second-highest revenue in vitro fertilization/IVF. The significant proportion of this category is due to the higher success percentage on the first try.
Some of the in vitro fertilization/IVF market’s latest advancements include disposable slides for sperm counting, an imaging-based monitoring system to extract the best motile sperm, and the usage of disposable microchips.
During the projection period, Asia-Pacific is expected to be the fastest-growing in vitro fertilization/IVF market. The in vitro fertilization/IVF market is being driven by several causes, including rising ovulation disorders in women, rising trends in assisted reproduction technologies, and rising rates of infertility. In addition, government programmes for fertility therapy are projected to provide in vitro fertilization/IVF market development opportunities.
Key Takeaways:
- In 2020, culture media dominated the in vitro fertilization/IVF market, accounting for more than 41% of total sales.
- In 2020, Europe dominated the worldwide in vitro fertilization/IVF market with a revenue share of about 37%.
- In 2020, the frozen non-donor category accounted for more than 47% of the total in vitro fertilization/IVF market sales.
- In 2020, the fertility clinics sector led the global in vitro fertilization/IVF market, accounting for more than 79% of total revenue.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14305
Competitive landscape:
CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. are some of the major competitors in the in vitro fertilization/IVF market. These in vitro fertilization/IVF market participants use a variety of marketing techniques to grow their in vitro fertilization/IVF market share, including mergers and acquisitions, product launches, and regional expansion.
Key Segments
By Product:
- Equipment
- Reagents and Media
- Accessories
By Cycle:
- Fresh non-donor cycle
- Frozen non-donor IVF cycle
- Frozen donor IVF cycle
- Fresh donor IVF cycle
By End User:
- Fertility Clinics
- Hospitals & Surgical Centers
- Cryobank and Research Institutes
By Type:
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
By Region:
- North America
- Latin America
- Middle East and Africa
- Asia Pacific
- Europe
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube